cbdMD YCBD
NYSE YCBD
$0.51 +0.00 (+0.77%)
As of: Aug 21, 2026 · 3:59 PM EDT

cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021)

cbdMD (YCBD) posted Non-Current Deferred Tax Liability of $6.1 million for Q3 2021, up 4604.62% sequentially from $130000.0 in Q2 2021, and up 583.35% YoY from $895000.0 in Q3 2020.

cbdMD (YCBD) Non-Current Deferred Tax Liability (2016 - 2021) Analysis & Trends

cbdMD has reported Non-Current Deferred Tax Liability for 6 years, with the latest figure at $6.1 million in Q3 2021.

  • Quarterly Non-Current Deferred Tax Liability rose 583.35% year-over-year to $6.1 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $6.1 million (up 583.35% YoY) and the FY2021 annual result came in at $6.1 million, up 583.35% from the prior year.
  • Non-Current Deferred Tax Liability rose to $6.1 million in Q3 2021 per YCBD's latest filing, from $130000.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $6.1 million in Q3 2021 and troughed at $15000.0 in Q4 2017.
  • A 5-year average of $1.7 million and a median of $563000.0 in 2020 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2018 and 2020: Non-Current Deferred Tax Liability jumped 33206.67% in 2018, then tumbled 60.05% in 2020.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $15000.0 in 2017, then surged by 33206.67% to $5.0 million in 2018, then tumbled by 55.16% to $2.2 million in 2019, then plunged by 74.87% to $563000.0 in 2020, then soared by 986.32% to $6.1 million in 2021.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.1 million, $130000.0, and $27000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 cbdMD 5.41 Mn 3.29 Mn 3.04 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 6.12 Mn
Sep 30, 2021 6.12 Mn
Jun 30, 2021 130,000.00
Jun 30, 2021 130,000.00
Mar 31, 2021 27,000.00
Mar 31, 2021 27,000.00
Dec 31, 2020 563,000.00
Dec 31, 2020 563,000.00
Sep 30, 2020 895,000.00
Sep 30, 2020 895,000.00
Sep 30, 2019 2.24 Mn
Sep 30, 2019 2.24 Mn
Jun 30, 2019 2.83 Mn
Jun 30, 2019 2.83 Mn
Mar 31, 2019 3.92 Mn
Mar 31, 2019 3.92 Mn
Dec 31, 2018 5.00 Mn
Dec 31, 2018 5.00 Mn
Sep 30, 2018 21,000.00
Sep 30, 2018 21,000.00